In an interview with Targeted OncologyTM, Ravi Muvner, MD, urologist at Hackensack University Medical Center, discusses how targeted therapies have changed the landscape of prostate cancer treatment.

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

As the leading cause of cancer-related death, lung cancer remains a noteworthy hazard to human health. NSCLC is the most ...

Researchers at the University of Texas at Dallas, led by bioengineering associate professor Dr. Girgis Obaid, are partnering ...

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Dr. Mostafa Madbouly, the Prime Minister, met on Monday, June 23, 2025, at the government headquarters in the New ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

At the cutting edge of TIL therapy development, Creative Biolabs offers end-to-end and integrated solutions dedicated to the unique needs of this dis ...

The global birch allergy market is experiencing robust growth due to increasing cases of allergic rhinitis from birch pollen and advancements in treatments like immunotherapy. Rising awareness and ...